BillionToOne unlocks 1+ million COVID-19 testing capacity per day in the US alone    |    + Learn more

BillionToOne Products

Make confident medical decisions.

By counting single molecules of DNA, we create diagnostics that reduce uncertainty and give clinicians and patients the clarity to make confident medical decisions.

The only blood test that shows your baby's risk for common and severe genetic diseases

Explore UNITYTM
Coming Soon

Cancer Liquid Biopsy

BillionToOne’s cancer diagnostic test lowers the limit of detection for gene amplifications by 10x so that these hallmarks of cancer are detected earlier.

let's partner

News & Media

BillionToOne, Inc Response to COVID-19

MAR 17 / 2020

In the News: BillionToOne Closes $15M in Series A Follow-on Round

MAR 10 / 2020

more

Build a career that counts.

We believe what we do should count.
It should make an impact.
It should change lives.

learn more

Covid-19 Response

BillionToOne unlocks 1+ million COVID-19 testing capacity per day in the US alone

using a unique testing protocol with 30X higher throughput

BillionToOne developed a novel qSanger-COVID-19 Test that is more than 30x higher throughput than existing quantitative PCR (qPCR) methods and is highly accurate and cost-effective.

Combining the unused Sanger sequencer capacity from the Human Genome project and the proprietary machine learning algorithm, BillionToOne’s qSanger-COVID-19 unlocks millions of daily testing capacity worldwide.

Test reagents will be made available in 2 weeks to clinical laboratories, pending manufacturing of kits and Emergency Use Authorization from FDA.

dismiss × Doing Our Part